ArticleEuropean journal of nuclear medicine and molecular imaging2024
Correction to: HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging.
Betül Altunay et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.